Case StudiesCase Study – December 2022
Our patient case study specially curated for you by our Faculty Member, Prof. Samer Ellahham on concerns about statin associated Diabetes Mellitus.
Patti G, Spinoni EG, Grisafi L, et al.
Journal: Eur Heart J Cardiovasc Pharmacother
First published: September 14, 2022 DOI: 10.1093/ehjcvp/pvac049
Case Study: RS is a 64-year-old Male having dyslipidemia.
Vital parameters: | BP 144/87 mm Hg Low-density lipoprotein cholesterol (LDL-C) 112 mg/dL High-density lipoprotein cholesterol (HDL-C) of 47 mg/dL Triglycerides 190 mg/dL (-) tobacco, (-) alcohol Body mass index (BMI) 33 kg/m2 |
Medication: | Valsartan 80 mg/d |
Family history: | Father developed type 2 diabetes mellitus (T2DM) and ASCVD at age 58 |
Labs: | Fasting blood glucose 103 mg/dL HbA1C 5.8% Serum Creatinine 1.1 mg/dL Urinary analysis within normal limits |
RS reports that he is reluctant to take statins as they cause diabetes especially with his family history.